Condition
Abnormal Uterine Bleeding Unrelated to Menstrual Cycle
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07137299Not Yet Recruiting
POPQ Associated With Total Laparoscopic Hysterectomy
NCT01762306Not ApplicableUnknownPrimary
Efficacy of Diclofenac on Pain During Endometrial Sampling
NCT01762319Not ApplicableUnknownPrimary
Cervical Ripening Before Endometrial Biopsy in Abnormal Uterine Bleeding Using Sublingual Misoprostol
Showing all 3 trials